InvestorsHub Logo
Followers 91
Posts 5592
Boards Moderated 0
Alias Born 06/05/2008

Re: None

Wednesday, 08/22/2018 1:03:28 PM

Wednesday, August 22, 2018 1:03:28 PM

Post# of 8172
Analyst upgrade by Thompson Reuters:

Thomson Reuters/Verus upgrades CELLECTAR BIOSCIENCES INC from HOLD to BUY.
BY Investars Analyst Actions - public
— 5:18 PM ET 08/20/2018
On August 20, 2018 Thomson Reuters/Verus upgraded CELLECTAR BIOSCIENCES INC ( CLRB
from HOLD to BUY

Surprised analysts are taking any notice of little old CLRB already. CT must be interesting to the professionals.

But as noted before, Company needs to get more products into Phase 2 clinical trials at their cash burn rate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News